-
Product Name
Elsilimomab (Synonyms: B-E8; MAB B-E8)
- Documents
-
Description
Anti-IL-6 / IFNb2 Antibody (Elsilimomab)
-
Tested applications
ELISA
-
Species reactivity
Human IL-6 / IFNb2
-
Alternative names
B-E8 antibody; MAB B-E8 antibody; ANTI-IL-6 MAB B-E8 antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-IL-6 / IFNb2 Antibody (elsilimomab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-IL-6 / IFNb2 Antibody (elsilimomab) is 98.96%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human IL-6 His at 2 ug/mL can bind Anti-IL-6 / IFNb2 Antibody (elsilimomab), EC50=0.0162 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"